Abstract:Osteosarcoma (OS) is the most common malignant bone tumor occurring mostly in children and adolescents between 10 and 20 years of age with poor response to current therapeutics. Alisertib (ALS, MLN8237) is a selective Aurora kinase A inhibitor that displays anticancer effects on several types of cancer. However, the role of ALS in the treatment of OS remains unknown. This study aimed to investigate the effects of ALS on the cell growth, apoptosis, autophagy, and epithelial to mesenchymal transition (EMT) and the underlying mechanisms in two human OS cell lines U-2 OS and MG-63. The results showed that ALS had potent growth inhibitory, pro-apoptotic, pro-autophagic, and EMT inhibitory effects on U-2 OS and MG-63 cells. ALS remarkably induced G2/M arrest and down-regulated the expression levels of cyclin-dependent kinases 1 and 2 and cyclin B1 in both U-2 OS and MG-63 cells. ALS markedly induced mitochondria-mediated apoptosis with a significant increase in the expression of key pro-apoptotic proteins and a decrease in main anti-apoptotic proteins. Furthermore, ALS promoted autophagic cell death via the inhibition of phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) and p38 mitogen-activated protein kinase (p38 MAPK) signaling pathways, and activation of 5'-AMP-dependent kinase (AMPK) signaling pathway. Inducers or inhibitors of apoptosis or autophagy simultaneously altered ALS-induced apoptotic and autophagic death in both U-2 OS and MG-63 cells, suggesting a crosstalk between these two primary modes of programmed cell death. Moreover, ALS suppressed EMT-like phenotypes with a marked increase in the expression of E-cadherin but a decrease in N-cadherin in U-2 OS and MG-63 cells. ALS treatment also induced reactive oxygen species (ROS) generation but inhibited the expression levels of sirtuin 1 and nuclear factor-erythroid-2-related factor 2 (Nrf2) in both cell lines. Taken together, these findings show that ALS promotes apoptosis and autophagy but inhibits EMT via PI3K/Akt/mTOR, p38 MAPK, and AMPK signaling pathways with involvement of ROS- and sirtuin 1-associated pathways in U-2 OS and MG-63 cells. ALS is a promising anticancer agent in OS treatment and further studies are needed to confirm its efficacy and safety in OS chemotherapy.

Effects of mineral trioxide aggregate (MTA) extracts on mitogen-activated protein kinase activity in human osteosarcoma cell line (U2OS)

In Vitro and in Vivo Killing Effects of Methionine Enkephalin on Osteosarcoma.

Matrine Induces Caspase-Dependent Apoptosis in Human Osteosarcoma Cells in Vitro and in Vivo Through the Upregulation of Bax and Fas/FasL and Downregulation of Bcl-2

Tetrandrine induces apoptosis and triggers a caspase cascade in U2-OS and MG-63 cells through the intrinsic and extrinsic pathways.

Evaluation of Human Osteosarcoma Cell Line Genotoxicity Effects of Mineral Trixoide Aggregate and Calcium Silicate Cements.

Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.

Comparison of Calcium and Silicate Cement and Mineral Trioxide Aggregate Biologic Effects and Bone Markers Expression in MG63 Cells

Anti-osteoclastogenesis of Mineral Trioxide Aggregate Through Inhibition of the Autophagic Pathway.

Arsenic Trioxide Inhibits Osteosarcoma Cell Invasiveness Via MAPK Signaling Pathway

The effects of mineral trioxide aggregate on osteo/odontogenic potential of mesenchymal stem cells: a comprehensive and systematic literature review

Honokiol Induces Apoptosis and Autophagy Via the ROS/ERK1/2 Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo.

The use of matrine to inhibit osteosarcoma cell proliferation via the regulation of the MAPK/ERK signaling pathway

Effect and Mechanism of Quercetin on Proliferation and Apoptosis of Human Osteosarcoma Cell U-2OS/MTX300

Mineral Trioxide Aggregate Promotes the Odonto/osteogenic Differentiation and Dentinogenesis of Stem Cells from Apical Papilla Via Nuclear Factor Kappa B Signaling Pathway.

Pro-apoptotic and Pro-Autophagic Effects of the Aurora Kinase A Inhibitor Alisertib (MLN8237) on Human Osteosarcoma U-2 OS and MG-63 Cells Through the Activation of Mitochondria-Mediated Pathway and Inhibition of P38 MAPK/PI3K/Akt/mTOR Signaling Pathway

Mometasone Furoate Inhibits Tumor Progression and Promotes Apoptosis Through Activation of the AMPK/mTOR Signaling Pathway in Osteosarcoma

Effects of the Myeloid Cell Nuclear Differentiation Antigen on the Proliferation, Apoptosis and Migration of Osteosarcoma Cells

Shock wave-induced ATP release from osteosarcoma U2OS cells promotes cellular uptake and cytotoxicity of methotrexate

Studies on biocompatibility of domestic MTA

The effect of arsenic trioxide on metastasis and invasion of human osteosarcoma cell

Gene Profiling of MAPK Pathway in Human Osteosarcoma